A BIOCOMPATIBLE THERAPEUTIC PLATFORM FOR PRECISE REGULATION OF VASCULARIZED COMPOSITE ALLOTRANSPLANT REJECTION VIA ENHANCED COSTIMULATION BLOCKAGE

The Geneva Foundation

Investigators